Aldose reductase-regulated tumor necrosis factor-α production is essential for high glucose-induced vascular smooth muscle cell growth

Endocrinology

Volumn 148, Issue 9, 2007, Pages 4371-4384

  Ramana, Kota V ^a   Tammali, Ravinder ^a   Reddy, Aramati B M ^a   Bhatnagar, Aruni ^b   Srivastava, Satish K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLGLUCOSE; 4,5 BIS(4 FLUOROANILINO)PHTHALIMIDE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; COMPLEMENTARY RNA; CYCLOHEXIMIDE; DACTINOMYCIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANNITOL; MESSENGER RNA; PROTEIN KINASE C BETA INHIBITOR; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; ROTTLERIN; SORBINIL; TOLRESTAT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA MEDIA; ARTICLE; AUTOCRINE EFFECT; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENZYME INHIBITION; GLUCOSE INTAKE; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; OSMOSIS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VASCULAR SMOOTH MUSCLE;

ALDEHYDE REDUCTASE; ANIMALS; AORTA; CELL DIVISION; GLUCOSE; HUMANS; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548084566     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0512     Document Type: Article

References (67)

1. Beckman JA, Creager MA, Libby P 2002 Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570-2581
2. Kannel WB, McGee DL 1979 Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59:8-13
3. Creager MA, Luscher TF, Cosentino F, Beckman JA 2003 Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108:1527-1532
4. Sheetz MJ, King GL 2002 Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288:2579-2588
5. Fernandez-Real JM, Ricart W 2003 Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278-301
6. Luft FC 2001 Angiotensin, inflammation, hypertension, and cardiovascular disease. Curr Hypertens Rep 3:61-67
7. Libby P 2002 Inflammation in atherosclerosis. Nature 420:868-874
8. Mann DL 2002 Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988-998
9. Nian M, Lee P, Khaper N, Liu P 2004 Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94:1543-1553
10. Yan SF, Ramasamy R, Naka Y, Schmidt AM 2003 Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93:1159-1169
11. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP 2001 The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50:2384-2389
12. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G 1999 Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353:1649-1652
13. Jain SK, Kannan K, Lim G, McVie R, Bocchini Jr JA 2002 Hyperketonemia increases tumor necrosis factor-α secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 51:2287-2293
14. Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F 2000 Tumour necrosis factor-α plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 248:67-76
15. Ben Mahmud BM, Mann GE, Datti A, Orlacchio A, Kohner EM, Chibber R 2004 Tumor necrosis factor-α in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy. Diabetes 53:2968-2976
16. Tuttle HA, Davis-Gorman G, Goldman S, Copeland JG, McDonagh PF 2004 Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. J Diabetes Complications 18:343-351
17. Torres SH, De Sanctis JB, de L Briceno M, Hernandez N, Finol HJ 2004 Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol 181:419-427
18. Sugimoto H, Shikata K, Wada J, Horiuchi S, Makino H 1999 Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42:878-886
19. Takeda R, Suzuki E, Satonaka H, Oba S, Nishimatsu H, Omata M, Fujita T, Nagai R, Hirata Y 2005 Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats. Circulation 111:1398-1406
20. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS 1997 Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389:610-614
21. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, Kollias G, Moller DE 1997 Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes 46:1526-1531
22. Schreyer SA, Chua Jr SC, LeBoeuf RC 1998 Obesity and diabetes in TNF-α. J Clin Invest 102:402-411
23. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-kappaB. Nat Med 11:183-190
24. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271:665-668
25. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF 2001 Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107:181-189
26. Virkamaki A, Ueki K, Kahn CR 1999 Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943
27. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP 2002 Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression. FASEB J 16:438-440
28. McMillan DE 1989 Increased levels of acute-phase serum proteins in diabetes. Metabolism 38:1042-1046
29. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK 2002 Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem 277:32063-32070
30. Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK 2004 Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 53:2910-2920
31. Ramana KV, Friedrich B, Tammali R, West MB, Bhatnagar A, Srivastava SK 2005 Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes 54:818-829
32. Detmer K, Wang Z, Warejcka D, Leeper-Woodford SK, Newman WH 2001 Endotoxin stimulated cytokine production in rat vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 281:H661-H668
33. Yamakawa T, Eguchi S, Matsumoto T, Yamakawa Y, Numaguchi K, Miyata I, Reynolds CM, Motley ED, Inagami T 1999 Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-κB and p38 mitogen-activated protein kinase on tumor necrosis factor-α production. Endocrinology 140:3562-3572
34. Baud V, Karin M 2001 Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372-377
35. Hattori Y, Hattori S, Sato N, Kasai K 2000 Vascular NAD(P)H oxidases: specific features, expression, and regulation. Cardiovasc Res 46:188-197
36. Lassegue B, Clempus RE 2003 Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297
37. Lee HS, Son SM, Kim YK, Hong KW, Kim CD 2003 NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells. Life Sci 72:2719-2730
38. Natarajan R, Gonzales N, Xu L, Nadler JL 1992 Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun 187:552-560
39. Watson PA, Nesterova A, Burant CF, Klemm DJ, Reusch JE 2001 Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J Biol Chem 276:46142-46150
40. Yasunari K, Kohno M, Kano H, Yokokawa K, Minami M, Yoshikawa J 1997 Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells. Circ Res 81:953-962
41. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D 2002 Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072
42. Guha M, Bai W, Nadler JL, Natarajan R 2000 Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275:17728-17739
43. Pickup JC, Chusney GD, Thomas SM, Burt D 2000 Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci 67:291-300
44. Ceriello A, Motz E 2004 Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816-823
45. Stern MP 1995 Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 44:369-374
46. Anderson HD, Rahmutula D, Gardner DG 2004 Tumor necrosis factor-α inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 279:963-969
47. Kim F, Gallis B, Corson MA 2001 TNF-α inhibits flow and insulin signaling leading to NO production in aortic endothelial cells. Am J Physiol Cell Physiol 280:C1057-C1065
48. Wang P, Ba ZF, Chaudry IH 1994 Administration of tumor necrosis factor-α in vivo depresses endothelium-dependent relaxation. Am J Physiol 266(6 Pt 2):H2535-H2541
49. Glass CK, Witztum JL 2001 Atherosclerosis the road ahead. Cell 104:503-516
50. Brownlee M 2001 Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
51. Srivastava SK, Ramana KV, Bhatnagar A 2005 Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26:380-392
52. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP 2001 Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792-2808
53. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R 1999 Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 48:855-864
54. Kislinger T, Fu C, Huber B, Qu W, Taquchi A, Du YS, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM 1999 N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740-31749
55. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E 2003 Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52:2570-2577
56. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T, Saya H, Hara E 2006 Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8:1291-1297
57. Gareskog M, Wentzel P 2007 N-Acetylcysteine and α-cyano-4-hydroxycinnamic acid alter protein kinase C (PKC)-δ and PKC-ζ and diminish dysmorphogenesis in rat embryos cultured with high glucose in vitro. J Endocrinol 192:207-214
58. Davies SP, Reddy H, Caivano M, Cohen P 2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105
59. Morishita R, Higaki J, Hayashi SI, Yo Y, Aoki M, Nakamura S, Moriguchi A, Matsushita H, Matsumoto K, Nakamura T, Ogihara T 1997 Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor. Diabetologia 40:1053-1061
60. Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE 2001 Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 50:851-860
61. Xia P, Kramer RM, King GL 1995 Identification of the mechanism for the inhibition of Na+, K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 96:733-740
62. Yasunari K, Kohno M, Kano H, Minami M, Yoshikawa J 2000 Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary artery smooth muscle cells induced by high glucose. Hypertension 35:1092-1098
63. Mehrhof FB, Schmidt-Ullrich R, Dietz R, Scheidereit C 2005 Regulation of vascular smooth muscle cell proliferation: role of NF-kappaB revisited. Circ Res 96:958-964
64. Garvey WT 1992 Glucose transport and NIDDM. Diabetes Care 15:396-417
65. Vuorinen-Markkola H, Koivisto VA, Yki-Jarvinen H 1992 Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes 41:571-580
66. Berti L, Mosthaf L, Kroder G, Kellerer M, Tippmer S, Mushack J, Seffer E, Seedorf K, Haring H 1994 Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem 269:3381-3386
67. Itani SI, Ruderman NB, Schmieder F, Boden G 2002 Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-2011